Nathan Chertack

Nathan Chertack

Auto-generated profile, based on publicly available information

Nathan Chertack

Department of Urology University of Texas Southwestern Medical Center Dallas Texas

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Urology
Verified
Journal Article
Closed access
NCNathan Chertack
Nathan Chertack
HCHemant Chaparala
Hemant Chaparala
KAKenneth W. Angermeier
Kenneth W. Angermeier
DMDrogo K. Montague
Drogo K. Montague
HWHadley M. Wood
Hadley M. Wood

10 August 2020 in Cancer
Verified
Journal Article
Closed access
PDF file
NCNathan Chertack
Nathan Chertack
RGRashed A. Ghandour
Rashed A. Ghandour
NSNirmish Singla
Nirmish Singla
YFYuval Freifeld
Yuval Freifeld
RHRyan C. Hutchinson
Ryan C. Hutchinson
ABAditya Bagrodia
Aditya Bagrodia

1 September 2017 in Urology
Verified
Journal Article
Closed access
SKSorena Keihani
Sorena Keihani
JCJason C Chandrapal
Jason C Chandrapal
APAndrew C Peterson
Andrew C Peterson
JBJoshua A Broghammer
Joshua A Broghammer
NCNathan Chertack
Nathan Chertack
T(Turnsresearch.Org) Trauma And Urologic Reconstruction Network Of Surgeons (Turns
Turnsresearch.Org) Trauma And Urologic Reconstruction Network Of Surgeons (Turns

1 August 2018 in Journal of Endourology
Verified
Journal Article
Closed access
NCNathan Chertack
Nathan Chertack
RJRajat Jain
Rajat Jain
MMManoj Monga
Manoj Monga
MNMark Noble
Mark Noble
SSSri Sivalingam
Sri Sivalingam
Introduction: Ureteral duplication is the most common ureteral anomaly, occurring in 0.6%–0.7% of the population. Our objective was to compare urolithiasis treatment outcomes in patients with and without ureteral duplication. Methods: Patients with ureteral duplication who underwent ureteroscopy (URS) were identified in a stone registry at a high-volume, tertiary care center from 1998 to 2015. Preoperative, intraoperative, and postoperative data were collected retrospectively. A 1:1 control cohort of patients without duplication was identified, matched by stone location and size, as well as age, body mass index (BMI), and gender. Clinical data and outcomes were compared between duplication and control groups, between partial and complete duplication groups, and between patients in whom duplication was identified intraoperatively vs known preoperatively. Results: Fifty patients with ureteral duplication who underwent URS were identified and were matched to 50 control patients. Patients with ureteral duplication required longer operative time (55 minutes vs 38.5 minutes, p = 0.022). Ureteral duplication had no effect on stone-free rates or need for additional procedures. High-grade (Clavien 4–5) complications were similar in both groups (4% vs 4%). Location of ureteral duplication and preoperative knowledge of ureteral duplication did not affect operative time or stone-free rates. Conclusions: Patients with ureteral duplication undergoing URS for urinary stone disease have longer operative times. Preoperative knowledge of ureteral duplication appears to have no significant effect on URS's safety or efficacy. In patients without a prior diagnosis of ureteral duplication, our data suggest that intraoperative detection via endoscopy and fluoroscopy is sufficient to safely and completely treat stone disease.

1 April 2016 in Journal of Urology
Verified
Journal Article
Closed access
HBHerman S. Bagga
Herman S. Bagga
SLSonghua Lin
Songhua Lin
AWAlun Williams
Alun Williams
JSJesse Schold
Jesse Schold
NCNathan Chertack
Nathan Chertack
HWHadley Wood
Hadley Wood
Improved bladder and renal management benefit patients with congenital uropathy and congenital pediatric kidney disease. This may translate to delayed initial renal transplantation in these patients, and improved graft and patient survival. Our primary study purpose was to determine whether patients with congenital uropathy and congenital pediatric kidney disease have demonstrated later time to first transplantation and/or graft survival. SRTR (Scientific Registry of Transplant Recipients) was analyzed for first renal transplant and survival data in patients with congenital uropathy and congenital pediatric kidney disease from 1996 to 2012. Congenital uropathy included chronic pyelonephritis/reflux, prune belly syndrome and congenital obstructive uropathy. Congenital pediatric kidney disease included polycystic kidney disease, hypoplasia, dysplasia, dysgenesis, agenesis and familial nephropathy. A total of 7,088 patients with congenital uropathy and 24,315 with congenital pediatric kidney disease received a first renal transplant from 1996 to 2012. A significant shift was seen in both groups toward older age at initial renal transplantation in those 18 through 64 years old. In the congenital uropathy group this effect was most facilitated by decreased renal transplantion in patients between 18 and 35 years old (38% in 1996 vs 26% in 2012). The congenital pediatric kidney disease group showed a substantial decrease in patients who were 35 to 49 years old (from 39% to 29%). At 10-year followup the congenital uropathy group showed better graft and patient survival than the congenital pediatric kidney disease group. However, aged matched comparison revealed comparable survival rates in the 2 groups. Analysis of trends in the last 14 years demonstrated that patients with both lower and upper tract congenital anomalies experienced delayed time to the first renal transplant. Furthermore, patients had similar age matched graft and patient survival whether the primary source of renal demise was the congenital lower or upper tract. These findings may indicate that improved urological and nephrological care are promoting renal preservation in both groups.

1 December 2017 in Translational Andrology and Urology
Verified
Journal Article
Closed access
PDF file
NCNathan Chertack
Nathan Chertack
BGBradley C. Gill
Bradley C. Gill
KAKenneth W. Angermeier
Kenneth W. Angermeier
DMDrogo K. Montague
Drogo K. Montague
HWHadley M. Wood
Hadley M. Wood
Background: To determine which preoperative factors drive patient-reported quality of life (QoL) after artificial urinary sphincter (AUS) implantation. Methods: Men receiving AUS after prostate cancer treatment were identified from a prospectively collected dataset. Preoperative factors were recorded during the initial incontinence consultation. Patients underwent urodynamic testing (UDS) preoperatively at surgeon discretion. Patients were surveyed by telephone postoperatively and given the EPIC Urinary Domain (EPIC-UD) and Urinary Distress Inventory (UDI-6) questionnaires. Differences in postoperative maximum pads per day (MxPPD) and questionnaire scores were compared across preoperative factors, with P¡Ü0.05 indicating statistical significance. Results: Telephone survey was completed by 101 of 238 patients (42%). Median age was 69 [63–75] years, BMI was 29 [26–32] kg/m2. MxPPD was 5 [3–9] preoperatively and 2 [1–3] postoperatively (r=0.255, P=0.011). Postoperative median EPIC-UD was 82 [67–89] and UDI-6 was 22 [11–36]. Postoperative MxPPD was lower in patients who reported being able to store urine before AUS {2 [1–2] vs. 2 [1–4], P=0.046}, and lower with urodynamically-proven detrusor overactivity (DO) {1.5 [1–2] with vs. 2 [1–4] without, P=0.050}. Detrusor pressure at maximum flow was negatively associated with QoL as measured by EPIC-UD score (r=−0.346, P=0.013) and UDI-6 score (r=0.413, P=0.003). Although 41 (41%) patients had a history of radiation, postoperative outcomes did not significantly differ with or without a history of radiation. Conclusions: Few preoperative factors predict QoL after AUS insertion.